Lynne A. Bui - 21 Mar 2022 Form 4 Insider Report for Hillstream BioPharma Inc. (THAR)

Role
Director
Signature
/s/ Randy Milby as Attorney-In-Fact for Lynne Bui
Issuer symbol
THAR
Transactions as of
21 Mar 2022
Net transactions value
$0
Form type
4
Filing time
23 Mar 2022, 16:15:42 UTC
Previous filing
11 Jan 2022
Next filing
09 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HILS Options (right to buy) Award $0 +50,000 $0.000000 50,000 21 Mar 2022 Common stock 50,000 $1.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 21, 2022, the Reporting Person was granted options ("Options") to purchase up to 50,000 shares of the Registrant's common stock pursuant to the Registrant's 2019 Stock Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant.